These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17017519)

  • 41. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E; Graybiel AM; Agid YA
    Nature; 1988 Jul; 334(6180):345-8. PubMed ID: 2899295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron accelerates the conversion of dopamine-oxidized intermediates into melanin and provides protection in SH-SY5Y cells.
    Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
    J Neurosci Res; 2005 Oct; 82(1):126-37. PubMed ID: 16108071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
    Wang J; Song N; Jiang H; Wang J; Xie J
    Biochim Biophys Acta; 2013 May; 1832(5):618-25. PubMed ID: 23376588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease.
    Ryu YK; Kang Y; Go J; Park HY; Noh JR; Kim YH; Hwang JH; Choi DH; Han SS; Oh WK; Lee CH; Kim KS
    J Med Food; 2017 Feb; 20(2):116-123. PubMed ID: 28146406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluazinam targets mitochondrial complex I to induce reactive oxygen species-dependent cytotoxicity in SH-SY5Y cells.
    Lee JE; Kang JS; Ki YW; Park JH; Shin IC; Koh HC
    Neurochem Int; 2012 Jun; 60(8):773-81. PubMed ID: 22465686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.
    Offen D; Ziv I; Barzilai A; Gorodin S; Glater E; Hochman A; Melamed E
    Neurochem Int; 1997 Aug; 31(2):207-16. PubMed ID: 9220453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iron, melanin and dopamine interaction: relevance to Parkinson's disease.
    Ben-Shachar D; Youdim MB
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):139-50. PubMed ID: 8416600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does autophagy worsen or improve the survival of dopaminergic neurons?
    Pasquali L; Ruggieri S; Murri L; Paparelli A; Fornai F
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S24-7. PubMed ID: 20123552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH; Kupsch A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease.
    Domingues AF; Arduíno DM; Esteves AR; Swerdlow RH; Oliveira CR; Cardoso SM
    Free Radic Biol Med; 2008 Sep; 45(6):820-5. PubMed ID: 18619530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.
    Lawana V; Um SY; Foguth RM; Cannon JR
    Neurotoxicology; 2020 Dec; 81():147-160. PubMed ID: 33058929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP
    Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.
    Hirsch EC
    Mol Neurobiol; 1994; 9(1-3):135-42. PubMed ID: 7888089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?
    Ross JM; Olson L; Coppotelli G
    Int J Mol Sci; 2015 Aug; 16(8):19458-76. PubMed ID: 26287188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
    Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
    Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells.
    Nakaso K; Yoshimoto Y; Yano H; Takeshima T; Nakashima K
    Neurosci Lett; 2004 Jan; 354(3):213-6. PubMed ID: 14700734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells.
    Ouazia D; Levros LC; Rassart E; Desrosiers RR
    Neuroscience; 2014 May; 267():263-76. PubMed ID: 24631677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.